Evaluating the effectiveness and safety of mepolizumab in elderly patients with severe asthma: insights from the REDES study
This study further supports mepolizumab as an effective and well tolerated therapy in the difficult to treat population of elderly patients with severe asthma.
Authors
- Tamara Hermida
- David Bañas-Conejero
- Santiago Quirce (ORCID: https://orcid.org/0000-0001-8086-0921)
- Ana Gómez-Bastero
- Mariana Muñoz Esquerre
- Miguel Díaz Palacios (ORCID: https://orcid.org/0000-0002-8492-7158)
- Eva Martínez‐Moragón (ORCID: https://orcid.org/0000-0001-8986-9463)
- Luís Puente‐Maestu (ORCID: https://orcid.org/0000-0001-8501-0117)
- Jacinto Ramos
- Celia Pinedo (ORCID: https://orcid.org/0000-0003-0432-2691)
Institutions
- Universidad Complutense de Madrid (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- Hospital Clínico San Carlos (ES)
- Instituto Universitario de La Paz (CO)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Hospital Universitario Virgen Macarena (ES)
- Complejo Hospitalario de Salamanca (ES)
- Hospital Universitario Doctor Peset (ES)
- Hospital Universitario Central de Asturias (ES)
Publication Details
- Journal
- Journal of Asthma
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1080/02770903.2025.2463956
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00